RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 62 filers reported holding RA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $2,539,000 | +1.8% | 52,894 | -0.5% | 0.01% | +25.0% |
Q4 2019 | $2,495,000 | +94.5% | 53,156 | -2.0% | 0.00% | +33.3% |
Q3 2019 | $1,283,000 | -11.5% | 54,230 | +12.5% | 0.00% | 0.0% |
Q2 2019 | $1,450,000 | +122.1% | 48,212 | +65.5% | 0.00% | +200.0% |
Q1 2019 | $653,000 | +59.7% | 29,135 | +29.5% | 0.00% | 0.0% |
Q4 2018 | $409,000 | +2.2% | 22,498 | +1.8% | 0.00% | 0.0% |
Q3 2018 | $400,000 | +81.8% | 22,109 | 0.0% | 0.00% | – |
Q2 2018 | $220,000 | +67.9% | 22,109 | -10.2% | 0.00% | – |
Q1 2018 | $131,000 | -17.6% | 24,616 | +31.6% | 0.00% | – |
Q4 2017 | $159,000 | -43.6% | 18,700 | -3.1% | 0.00% | -100.0% |
Q3 2017 | $282,000 | -27.7% | 19,300 | -7.2% | 0.00% | 0.0% |
Q2 2017 | $390,000 | +11.1% | 20,800 | +26.1% | 0.00% | 0.0% |
Q1 2017 | $351,000 | +36.6% | 16,500 | -2.4% | 0.00% | 0.0% |
Q4 2016 | $257,000 | – | 16,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 6,138,797 | $288,094,000 | 13.62% |
RA Capital Management | 4,858,260 | $227,998,000 | 6.91% |
HAVENS ADVISORS LLC | 116,000 | $5,444,000 | 4.77% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,115,600 | $99,286,000 | 3.16% |
SYQUANT CAPITAL SAS | 129,690 | $6,086,000 | 3.13% |
BARDIN HILL MANAGEMENT PARTNERS LP | 391,758 | $18,386,000 | 3.02% |
Kellner Capital, LLC | 91,100 | $4,275,000 | 2.71% |
Telemetry Investments, L.L.C. | 17,100 | $803,000 | 2.68% |
Versor Investments LP | 1,002,649 | $47,054,000 | 2.38% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,519,718 | $71,320,000 | 2.28% |